4.5 Article

Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Letter Immunology

The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection

Barnaby E. Young et al.

CLINICAL INFECTIOUS DISEASES (2016)

Article Infectious Diseases

Impact of vancomycin faecal concentrations on clinical and microbiological outcomes in Clostridium difficile infection

Abrar K. Thabit et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)

Article Medicine, General & Internal

Burden of Clostridium difficile Infection in the United States

Fernanda C. Lessa et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Economics

A Review of the Economics of Treating Clostridium difficile Infection

Kari A. Mergenhagen et al.

PHARMACOECONOMICS (2014)

Review Gastroenterology & Hepatology

Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections

Christina M. Surawicz et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

Fidaxomicin versus Vancomycin for Clostridium difficile Infection

Thomas J. Louie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Article Gastroenterology & Hepatology

Outcomes of Clostridium difficile-associated disease treated with metronidazole or vancomycin before and after the emergence of NAP1/027

Jacques Pepin et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)

Article Public, Environmental & Occupational Health

Recommendations for surveillance of Clostridium difficile-associated disease

L. Clifford McDonald et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)

Article Medicine, General & Internal

An epidemic, toxin gene-variant strain of Clostridium difficile

LC McDonald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)